Retraction: JNK Contributes to the Tumorigenic Potential of Human Cholangiocarcinoma Cells through the mTOR Pathway Regulated GRP78 Induction

The PLOS ONE Editors

DOI: https://doi.org/10.1371/journal.pone.0310934

IF: 3.7

2024-09-19

PLoS ONE

Abstract:After this article [1] was published, concerns were raised about results presented in Figs 1, 5, 6, and 7.

multidisciplinary sciences

What problem does this paper attempt to address?

Retraction: Identification of RegIV as a Novel GLI1 Target Gene in Human Pancreatic Cancer

The PLOS ONE Editors

DOI: https://doi.org/10.1371/journal.pone.0298197

IF: 3.7

2024-01-31

PLoS ONE

Abstract:Following the publication of this article [1, 2], concerns were raised regarding Figure 8, and additional issues were noted upon editorial follow up. Specifically,

multidisciplinary sciences
RETRACTION: SLC1A3 Promotes Gastric Cancer Progression via the PI3K/AKT Signalling Pathway

DOI: https://doi.org/10.1111/jcmm.18568

Abstract:Xu L, Chen J, Jia L, Chen X, Moumin FA, Cai J. SLC1A3 Promotes Gastric Cancer Progression via the PI3K/AKT Signalling Pathway. Journal of Cellular and Molecular Medicine 2020;24(24):14392-14404. https://doi.org/10.1111/jcmm.16060 The above article, published online on 3 November 2020 in Wiley Online Library (wileyonlinelibrary.com), has been retracted by agreement between the journal Editor-in-Chief, Stefan N. Constantinescu; the Foundation for Cellular and Molecular Medicine; and John Wiley & Sons Ltd. The retraction has been agreed due to concerns raised by third parties. Specifically, image elements of Figure 6G were found to have been previously published in a different scientific context.1 The corresponding author stated that a third-party company partially generated the data presented in the article and suggested there may have been mishandling of the data. Additionally, the article mentions use of the unverifiable/unknown cell line GSE-1 and presents results from the cell line MKN-28, reported as misidentified by the Japanese Collection of Research Bioresources (JCRB) Cell Bank of the National Institutes of Biomedical Innovation, Health and Nutrition (https://cellbank.nibiohn.go.jp/). Therefore, the editors consider the conclusions of this article to be invalid. The authors have been informed of the decision of retraction. [1] Pang X, Li R, Shi D, Pan X, Ma C, Zhang G, Mu C, Chen W. Knockdown of Rhotekin 2 expression suppresses proliferation and induces apoptosis in colon cancer cells. Oncol Lett. 2017;14(6):8028-8034. https://doi.org/10.1111/jcmm.16060.
Retraction: Antitumor Activity of Sorafenib in Human Cancer Cell Lines with Acquired Resistance to EGFR and VEGFR Tyrosine Kinase Inhibitors

The PLOS ONE Editors

DOI: https://doi.org/10.1371/journal.pone.0298013

IF: 3.7

2024-01-26

PLoS ONE

Abstract:Following the publication of this article [1] and the subsequent Expression of Concern [2] further concerns were raised regarding Figures 3 and 4. Specifically:

multidisciplinary sciences
[Retracted] MicroRNA‐520a attenuates proliferation of Raji cells through inhibition of AKT1/NF‐κB and PERK/eIF2α signaling pathway

Xiaojuan Wang,Pei Wang,Yan Zhu,Zhi Zhang,Jinqian Zhang,Hongwei Wang

DOI: https://doi.org/10.3892/or.2024.8706

2024-01-23

Oncology Reports

Abstract:Following the publication of this paper, it was drawn to the Editors' attention by a concerned reader that a pair of the lanes featured in the western blot gel for Fig. 3B on p. 1705 were strikingly similar, suggesting that the same data may have been imported into the figure to represent data that were intended to show the results from differently performed experiments. In addition, the western data shown in Fig. 6 on p. 1706 for the GRP78 and the p‐PERK proteins also appeared to be strikingly similar, such that the same data may have also been inserted into this figure to show the results from different experiments. Finally, certain of the data in this paper were shown to have appeared in a previous publication that featured some of the same authors, albeit in different form [Zhang L, Huang D, Wang Q, Shen D, Wang Y, Chen B, Zhang J and Gai L: MiR‐132 inhibits expression of SIRT1 and induces pro‐inflammatory processes of vascular endothelial inflammation through blockade of the SREBP‐1c metabolic pathway. Cardiovasc Drugs Ther 8: 303‐311, 2014]. Owing to the fact that some of the contentious data in the above article had already been published elsewhere prior to its submission to Oncology Reports , and because of an overall lack of confidence in the presented data, the Editor has decided that this paper should be retracted from the Journal. The authors were asked for an explanation to account for these concerns, but the Editorial Office did not receive a reply. The Editor apologizes to the readership for any inconvenience caused. [Oncology Reports 36: 1702‐1708, 2016; DOI: 10.3892/or.2016.4975]

oncology
[Retracted] Tunicamycin inhibits colon carcinoma growth and aggressiveness via modulation of the ERK‐JNK‐mediated AKT/mTOR signaling pathway

Shuping You,Weihong Li,Yun Guan

DOI: https://doi.org/10.3892/mmr.2024.13184

IF: 3.423

2024-02-20

Molecular Medicine Reports

Abstract:Following the publication of this paper, it was drawn to the Editor's attention by a concerned reader that certain of the Transwell invasion and migration assay data shown in Fig. 1B and C were strikingly similar to data appearing in different form in other articles written by different authors at different research institutes, which had either already been published or were under consideration for publication at around the same time. Owing to the fact that the contentious data in the above article had already been published prior to its submission to Molecular Medicine Reports , the Editor has decided that this paper should be retracted from the Journal. The authors were asked for an explanation to account for these concerns, but the Editorial Office did not receive a reply. The Editor apologizes to the readership for any inconvenience caused. [Molecular Medicine Reports 17: 4203‐4212, 2018; DOI: 10.3892/mmr.2018.8444]

oncology,medicine, research & experimental
Retraction Note: STAT5A reprograms fatty acid metabolism and promotes tumorigenesis of gastric cancer cells

S-R Dong,X-L Ju,W-Z Yang

DOI: https://doi.org/10.26355/eurrev_202409_36716

Abstract:The article "STAT5A reprograms fatty acid metabolism and promotes tumorigenesis of gastric cancer cells" by S.-R. Dong, X.-L. Ju, W.-Z. Yang, published in Eur Rev Med Pharmacol Sci 2019; 23 (19): 8360-8370 - PMID: 31646566 has been retracted by the Editor in Chief following the expression of concern published in May 2024, available at https://www.europeanreview.org/article/36273. Following concerns raised by third party and by readers on PubPeer (link: https://pubpeer.com/publications/2D2719EECB2A38AFB430AE920E0ADD), the Editor in Chief has started an investigation to assess the validity of the results as well as possible figure manipulation. The journal's investigation revealed duplications involving Figure 2F, Figure 3I, and Figure 4D with previously published articles (https://doi.org/10.18632/aging.102995 and https://doi.org/10.2147/DDDT.S151029). Additionally, a duplication was found between the GAPDH panels of MKN28 and AGS in Figure 3C. The authors have been informed about the journal's investigation but remained unresponsive and have not provided the study's raw data. Consequently, the Editor in Chief mistrusts the results presented and has decided to retract the article. This article has been retracted. The Publisher apologizes for any inconvenience this may cause. https://www.europeanreview.org/article/19147.
Retraction: Gadd153 and NF-κB Crosstalk Regulates 27-Hydroxycholesterol-Induced Increase in BACE1 and β-Amyloid Production in Human Neuroblastoma SH-SY5Y Cells

The PLOS ONE Editors

DOI: https://doi.org/10.1371/journal.pone.0307676

IF: 3.7

2024-07-19

PLoS ONE

Abstract:After this article [1] was published, concerns were raised about results presented in Figures 1, 3, and 4. Specifically:

multidisciplinary sciences
[Retracted] Mammalian STE20‑like kinase 1 regulates pancreatic cancer cell survival and migration through Mfn2‑mediated mitophagy

Yongli Hu,Bing Wang,Lie Wang,Zhenran Wang,Zhiyuan Jian,Lin Deng

DOI: https://doi.org/10.3892/mmr.2024.13294

Abstract:Following the publication of this paper, it was drawn to the Editors' attention by a concerned reader that certain of the JC‑1 staining images in Fig. 2C were strikingly similar to data appearing in different form in other articles written by different authors at different research institutes that had either already been published elsewhere prior to the submission of this paper to Molecular Medicine Reports, or were under consideration for publication at around the same time (a small number of which have been retracted). In addition, the Snail western blot data in Fig. 3E bore a close similarity to certain of the Mfn2 data shown in Fig. 4A. In view of the fact that certain of the contentious data had already apparently been published previously, and owing to a lack of confidence in the presentation of certain of the data in this paper, the Editor of Molecular Medicine Reports has decided that this paper should be retracted from the Journal. The authors were asked for an explanation to account for these concerns, but the Editorial Office did not receive a reply. The Editor apologizes to the readership for any inconvenience caused. [Molecular Medicine Reports 22: 398‑404, 2020; DOI: 10.3892/mmr.2020.11098].
[Retracted] Activation of the LKB1‐SIK1 signaling pathway inhibits the TGF‐β‐mediated epithelial‐mesenchymal transition and apoptosis resistance of ovarian carcinoma cells

Bo Hong,Jianmei Zhang,Wenlan Yang

DOI: https://doi.org/10.3892/mmr.2024.13180

IF: 3.423

2024-02-10

Molecular Medicine Reports

Abstract:Following the publication of this paper, it was drawn to the Editor's attention by a concerned reader that certain of the Transwell invasion and migration assay data shown in Figs. 2C and 3F were strikingly similar to data appearing in different form in other articles written by different authors at different research institutes, which had either already been published or were under consideration for publication at around the same time. Owing to the fact that the contentious data in the above article had already been published prior to its submission to Molecular Medicine Reports , the Editor has decided that this paper should be retracted from the Journal. The authors were asked for an explanation to account for these concerns, but the Editorial Office did not receive a reply. The Editor apologizes to the readership for any inconvenience caused. [Molecular Medicine Reports 17: 2837‐2844, 2018; DOI: 10.3892/mmr.2017.8229]

oncology,medicine, research & experimental
Retraction: YY1 suppresses proliferation and migration of pancreatic ductal adenocarcinoma by regulating the CDKN3/MdM2/P53/P21 signaling pathway

DOI: https://doi.org/10.1002/ijc.34803

2024-03-01

Abstract:Liu D, Zhang J, Wu Y, et al. YY1 suppresses proliferation and migration of pancreatic ductal adenocarcinoma by regulating the CDKN3/MdM2/P53/P21 signaling pathway. Int. J. Cancer. 2018;142: 1392-1404. https://doi.org/10.1002/ijc.31173 The above article, published online 23 Nov 2017 on Wiley Online Library (https://onlinelibrary.wiley.com/doi/pdf/10.1002/ijc.31173), has been retracted by agreement between the authors, the journal Editor-in-Chief, Prof. Christoph Plass, the Union for International Cancer Control-UICC, and Wiley Periodicals LLC. The retraction has been agreed due to concerns raised by the editorial team after a systematic internal investigation and some of the issues have also been noticed by a third party. The detailed analysis of the published images revealed incorrect duplications in Figures 1e, f, g, h; 2f, g; 3e, f; 6f and Supplementary Figures S2B; S3A, B. As a result, due to the number and severity of the problems, the conclusions of the article are considered unreliable.
Mst1-Hippo Pathway Triggers Breast Cancer Apoptosis via Inducing Mitochondrial Fragmentation in a Manner Dependent on JNK–Drp1 Axis

Hui Ouyang,Enxiang Zhou,Huan Wang

DOI: https://doi.org/10.2147/ott.s464002

IF: 4

2024-02-15

OncoTargets and Therapy

Abstract:Ouyang H, Zhou E, Wang H. Onco Targets Ther . 2019:12;1147–1159 We, the Editors and Publisher of OncoTargets and Therapy , have retracted the following article. Following publication of the article, concerns were raised about the duplication of images from Figures 2, 3, 4 and 5 with images from other unrelated articles. Specifically, The authors did not respond to our queries and were unable to provide an explanation for the duplicated images or provide data for the study. As verifying the validity of published work is core to the integrity of the scholarly record, we are therefore retracting the article and the authors were notified of this. We have been informed in our decision-making by our editorial policies and COPE guidelines. The retracted article will remain online to maintain the scholarly record, but it will be digitally watermarked on each page as "Retracted". This retraction relates to this paper

oncology,biotechnology & applied microbiology
[Retracted] Matrine inhibits ovarian cancer cell viability and promotes apoptosis by regulating the ERK/JNK signaling pathway via p38MAPK

Xin Liang,Jianxin Ju

DOI: https://doi.org/10.3892/or.2024.8758

Abstract:Following the publication of the above article, a concerned reader drew to the Editor's attention that certain of the Transwell cell invasion assay data featured in Fig. 1B and C, the immunofluorescence assay data in Fig. 2E and F, the TUNEL assay data in Fig. 4C and the immunohistochemical data in Fig. 4B and E were strikingly similar to data appearing in different form in other articles written by different authors at different research institutes that had either already been published elsewhere prior to the submission of this paper to Oncology Reports, or which under consideration for publication at around the same time. In view of the fact that certain of these data had already apparently been published prior to the submission of this article for publication, the Editor of Oncology Reports has decided that this paper should be retracted from the Journal. The authors were asked for an explanation to account for these concerns, but the Editorial Office did not receive a reply. The Editor apologizes to the readership for any inconvenience caused. [Oncology Reports 45: 82, 2021; DOI: 10.3892/or.2021.8033].
[Retracted] Schisandrin B inhibits epithelial‐mesenchymal transition and stemness of large‐cell lung cancer cells and tumorigenesis in xenografts via inhibiting the NF‐κB and p38 MAPK signaling pathways

Shuping Li,Hong Wang,Ruidong Ma,Li Wang

DOI: https://doi.org/10.3892/or.2024.8761

2024-06-27

Oncology Reports

Abstract:Following the publication of the above article, a concerned reader drew to the Editor's attention that certain of the Transwell cell invasion and migration assay data featured in Figs. 2D and 5E and the wound‐healing assay data in Fig. 2A were strikingly similar to data appearing in different form in other articles written by different authors at different research institutes that had either already been published elsewhere prior to the submission of this paper to Oncology Reports , or which under consideration for publication at around the same time. In view of the fact that certain of these data had already apparently been published prior to the submission of this article for publication, the Editor of Oncology Reports has decided that this paper should be retracted from the Journal. The authors were asked for an explanation to account for these concerns, but the Editorial Office did not receive a reply. The Editor apologizes to the readership for any inconvenience caused. [Oncology Reports 45: 115, 2021; DOI: 10.3892/or.2021.8066]

oncology
Retraction: MicroRNA-330 Is an Oncogenic Factor in Glioblastoma Cells by Regulating SH3GL2 Gene

The PLOS ONE Editors

DOI: https://doi.org/10.1371/journal.pone.0297950

IF: 3.7

2024-01-25

PLoS ONE

Abstract:After this article [1] was published, concerns were raised about results reported in Figs 3 and 5.

multidisciplinary sciences
RETRACTION: MCCK1 enhances the anticancer effect of temozolomide in attenuating the invasion, migration and epithelial-mesenchymal transition of glioblastoma cells in vitro and in vivo

DOI: https://doi.org/10.1002/cam4.70300

Abstract:Retraction: T. Liu, A. Li, Y. Xu, and Y. Xin, "MCCK1 Enhances the Anticancer Effect of Temozolomide in Attenuating the Invasion, Migration and Epithelial-Mesenchymal Transition of Glioblastoma Cells in Vitro and in Vivo," Cancer Medicine 8, no. 2 (2019): 751-760. https://doi.org/10.1002/cam4.1951. The above article, published online on 18 January 2019, in Wiley Online Library (wileyonlinelibrary.com), has been retracted by agreement between the authors, the journal Editor-in-Chief, Stephen Tait, and John Wiley & Sons Ltd. A report submitted by a third party noted image duplications with other articles by different author groups. Specifically, the report found image duplications with other published articles in Figures 1E, 2B, 3A, 3D and 4C. The report also found image overlap between images in Figure 3A. The retraction has been agreed to because the evidence of image duplication across different articles, each of which describes different experimental conditions, fundamentally compromises the editors' confidence in the conclusions presented. The authors have voluntarily agreed with the retraction.
Retracted: A Study on Curcumol Influencing Proliferation and Apoptosis of Hepatocellular Carcinoma Cells through DJ-1/PTEN/PI3K/AKT Pathway

BioMed Research International

DOI: https://doi.org/10.1155/2024/9781784

2024-01-09

BioMed Research International

Abstract:[This retracts the article DOI: 10.1155/2022/9912776.].

biotechnology & applied microbiology,medicine, research & experimental
RETRACTION: The long noncoding RNA AK002107 negatively modulates miR-140-5p and targets TGFBR1 to induce epithelial-mesenchymal transition in hepatocellular carcinoma

DOI: https://doi.org/10.1002/1878-0261.13677

Abstract:Tang, Y. H., He, G. L., Huang, S. Z., Zhong, K. B., Liao, H., Cai, L., Gao, Y., Peng, Z. W., & Fu, S. J. (2019), The long noncoding RNA AK002107 negatively modulates miR-140-5p and targets TGFBR1 to induce epithelial-mesenchymal transition in hepatocellular carcinoma. Mol Oncol, 13(5): 1296-1310. https://doi.org/10.1002/1878-0261.12487. The above article, published online on 11 April 2019 in Wiley Online Library (wileyonlinelibrary.com), has been retracted by agreement between the journal Editor-in-Chief, Kevin Ryan, FEBS Press, and John Wiley and Sons Ltd. The retraction has been agreed following an investigation into concerns raised by a third party, which revealed image duplication between figure 2D of this manuscript and figure 4G of an earlier publication by different authors [1]. The authors provided images of the trays of cell colonies which match the panels in figure 2, but did not provide a compelling explanation for the image duplication with the earlier publication [1]. Therefore, the editors consider the conclusions of the study to be substantially compromised and are retracting the article. The authors do not agree with the retraction. Reference [1] Zeng JD, Zhang N, Zhao GJ, Xu LX, Yang Y, Xu XY, Chen MK, Wang HY, Zheng SX, Li XX. (2018) MT1G is Silenced by DNA Methylation and Contributes to the Pathogenesis of Hepatocellular Carcinoma. J Cancer, 9(16): 2807-2816. https://doi.org/10.7150/jca.25680.
RETRACTED: Protective Autophagy Induced by Physcion Suppresses Hepatocellular Carcinoma Cell Metastasis by Inactivating the JAK2/STAT3 Axis.

Xiaoping Pan,Chen Wang,Yan Li,Lida Zhu,Ti Zhang

DOI: https://doi.org/10.1016/j.lfs.2018.10.064

IF: 6.78

2018-01-01

Life Sciences

Abstract:This article has been retracted: please see Elsevier Policy on Article Withdrawal (https://www.elsevier.com/about/our-business/policies/article-withdrawal).This article has been retracted at the request of the Editor-in-Chief and the authors, as panels from Figure 6F appear as similar to panels from Figure 2B of the article published by Ming-Quan Gao, Hui Gao, Mei Han, Kai-Li Liu, Jian-Jun Peng and Yan-Tao Han in the American Journal of Cancer Research 7 (2017) 1501–1514 https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5523031/ and Figures 2E and 3E of the article published by Meizhi Wang, Hui Gao, Haijun Qu, Jing Li, Kaili Liu and Zhiwu Han in Pharmacological Reports 70 (2018) 963–971 https://doi.org/10.1016/j.pharep.2018.04.006.Also, the Vehicle panel from Figure 7E appears as similar to the Vehicle panel from Figure 3D of the article published by Bo Liu and Shuo Yu in Biomedicine & Pharmacotherapy 107 (2018) 243–253 https://doi.org/10.1016/j.biopha.2018.07.177.Figure 7E appears also as similar to Figure 6(b) of the article published by Mei Han, Hui Gao, Jing Xie, Yin-ping Yuan, Quan Yuan, Ming-quan Gao, Kai-li Liu, Xue-hong Chen, Yan-tao Han and Zhi-wu Han in Acta Pharmacologica Sinica volume 40 (2019) 666–676 https://doi.org/10.1038/s41401-018-0159-7.Moreover, panels from Figure 7F appear as similar to panels from Figure 7E of the Reference [1], Figure 6D of the Reference [2], Figure 6C of the Reference [3], Figure 8C of the Reference [4], Figure 8D of the Reference [5] and Figure 6B of the Reference [6].One of the conditions of submission of a paper for publication is that authors declare explicitly that their work is original and has not appeared in a publication elsewhere. Re-use of any data should be appropriately cited. As such this article represents a severe abuse of the scientific publishing system. The scientific community takes a very strong view on this matter and apologies are offered to readers of the journal that this was not detected during the submission process.
TNFα Promotes Glioblastoma A172 Cell Mitochondrial Apoptosis via Augmenting Mitochondrial Fission and Repression of MAPK–ERK–YAP Signaling Pathways

Changyu Lu,Xiaolei Chen,Qun Wang,Xinghua Xu,Bainan Xu

DOI: https://doi.org/10.2147/ott.s471180

IF: 4

2024-04-04

OncoTargets and Therapy

Abstract:Lu C, Chen X, Wang Q, Xu X, Xu B. Onco Targets Ther . 2018;11:7213–7227. We, the Editors and Publisher of OncoTargets and Therapy , have retracted the following article. Following publication of the article, concerns were raised about the duplication of images from Figures 1, 2, 3, 4, 5, and 6 with images from other unrelated articles. Specifically, The authors did not respond to our queries and were unable to provide an explanation for the duplicated images or provide data for the study. As verifying the validity of published work is core to the integrity of the scholarly record, we are therefore retracting the article and the authors were notified of this. We have been informed in our decision-making by our editorial policies and COPE guidelines. The retracted article will remain online to maintain the scholarly record, but it will be digitally watermarked on each page as "Retracted". This retraction relates to this paper

oncology,biotechnology & applied microbiology
Statement of Retraction: TGF-β is associated with poor prognosis and promotes osteosarcoma progression via PI3K/Akt pathway activation

DOI: https://doi.org/10.1080/15384101.2022.2046822

2022-03-18

Cell Cycle

Abstract:We, the Editors and Publisher of the journal Cell Cycle, have retracted the following article:

cell biology

Retraction: JNK Contributes to the Tumorigenic Potential of Human Cholangiocarcinoma Cells through the mTOR Pathway Regulated GRP78 Induction

Retraction: Identification of RegIV as a Novel GLI1 Target Gene in Human Pancreatic Cancer

RETRACTION: SLC1A3 Promotes Gastric Cancer Progression via the PI3K/AKT Signalling Pathway

Retraction: Antitumor Activity of Sorafenib in Human Cancer Cell Lines with Acquired Resistance to EGFR and VEGFR Tyrosine Kinase Inhibitors

[Retracted] MicroRNA‐520a attenuates proliferation of Raji cells through inhibition of AKT1/NF‐κB and PERK/eIF2α signaling pathway

[Retracted] Tunicamycin inhibits colon carcinoma growth and aggressiveness via modulation of the ERK‐JNK‐mediated AKT/mTOR signaling pathway

Retraction Note: STAT5A reprograms fatty acid metabolism and promotes tumorigenesis of gastric cancer cells

Retraction: Gadd153 and NF-κB Crosstalk Regulates 27-Hydroxycholesterol-Induced Increase in BACE1 and β-Amyloid Production in Human Neuroblastoma SH-SY5Y Cells

[Retracted] Mammalian STE20‑like kinase 1 regulates pancreatic cancer cell survival and migration through Mfn2‑mediated mitophagy

[Retracted] Activation of the LKB1‐SIK1 signaling pathway inhibits the TGF‐β‐mediated epithelial‐mesenchymal transition and apoptosis resistance of ovarian carcinoma cells

Retraction: YY1 suppresses proliferation and migration of pancreatic ductal adenocarcinoma by regulating the CDKN3/MdM2/P53/P21 signaling pathway

Mst1-Hippo Pathway Triggers Breast Cancer Apoptosis via Inducing Mitochondrial Fragmentation in a Manner Dependent on JNK–Drp1 Axis

[Retracted] Matrine inhibits ovarian cancer cell viability and promotes apoptosis by regulating the ERK/JNK signaling pathway via p38MAPK

[Retracted] Schisandrin B inhibits epithelial‐mesenchymal transition and stemness of large‐cell lung cancer cells and tumorigenesis in xenografts via inhibiting the NF‐κB and p38 MAPK signaling pathways

Retraction: MicroRNA-330 Is an Oncogenic Factor in Glioblastoma Cells by Regulating SH3GL2 Gene

RETRACTION: MCCK1 enhances the anticancer effect of temozolomide in attenuating the invasion, migration and epithelial-mesenchymal transition of glioblastoma cells in vitro and in vivo

Retracted: A Study on Curcumol Influencing Proliferation and Apoptosis of Hepatocellular Carcinoma Cells through DJ-1/PTEN/PI3K/AKT Pathway

RETRACTION: The long noncoding RNA AK002107 negatively modulates miR-140-5p and targets TGFBR1 to induce epithelial-mesenchymal transition in hepatocellular carcinoma

RETRACTED: Protective Autophagy Induced by Physcion Suppresses Hepatocellular Carcinoma Cell Metastasis by Inactivating the JAK2/STAT3 Axis.

TNFα Promotes Glioblastoma A172 Cell Mitochondrial Apoptosis via Augmenting Mitochondrial Fission and Repression of MAPK–ERK–YAP Signaling Pathways

Statement of Retraction: TGF-β is associated with poor prognosis and promotes osteosarcoma progression via PI3K/Akt pathway activation